Daiwa Securities Group Inc. Rubius Therapeutics, Inc. Transaction History

Daiwa Securities Group Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 05, 2021	BUY	$17.6 - $25.91 $2,270 - $3,342	129 Added 72.47%	307 $5,000
Q4 2020 Feb 04, 2021	SELL	$4.23 - $8.73 $1,150 - $2,374	-272 Reduced 60.44%	178 $1,000
Q4 2019 Jan 31, 2020	SELL	$7.23 - $14.12 $383 - $748	-53 Reduced 10.54%	450 $4,000
Q1 2019 Apr 26, 2019	SELL	$13.27 - $18.51 $1,778 - $2,480	-134 Reduced 21.04%	503 $9,000
Q4 2018 Feb 05, 2019	BUY	$13.83 - $22.97 $8,809 - $14,631	637 New	637 $10,000

325

Ticker RUBY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 90,357,000
Description
Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of red cell therapeutics (RCTs) for the treatment of patients with severe diseases. The company is developing RTX-240 and RTX-224 for the treatment of solid tumors cancer; and RTX-aAPC to treat cancers. It is also developing RTX-321 for the treatmen...

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

Stay updated on Daiwa Securities Group Inc. with notifications on news.